iPSCs, aging and age-related diseases

Area of Science:

• Regenerative Medicine
• Stem Cell Biology
• Immunology

Background:

• Human histocompatibility antigens cause transplanted tissue rejection.
• Induced pluripotent stem cells (iPSCs) offer potential for immune-compatible transplantation.
• Generating iPSCs from elderly patients is crucial for regenerative medicine in aging populations.

Purpose of the Study:

• To review the potential of iPSCs for regenerative medicine, particularly in elderly patients.
• To discuss the generation and differentiation capabilities of iPSCs from aged individuals.
• To highlight challenges and progress in the clinical application of iPSCs for age-related diseases.

Main Methods:

• Review of recent findings on iPSC generation from aged mice and humans.
• Analysis of iPSC differentiation potential into various cell types.
• Discussion of critical issues for clinical iPSC use: senescence, copy number variation, tumorigenicity, and immunogenicity.

Main Results:

• iPSCs can be successfully generated from aged mice and humans.
• These aged iPSCs retain the ability to differentiate into cells from all three germ layers.
• iPSCs have been differentiated into cell types relevant to age-related diseases like atherosclerosis, diabetes, Alzheimer's, and Parkinson's.

Conclusions:

• iPSC technology holds significant promise for personalized stem cell transplantation therapy for incurable diseases in the elderly.
• Further research is needed to address senescence, genetic stability, and immunogenicity before widespread clinical application.
• Successful generation of disease-specific iPSCs from aged individuals paves the way for novel therapeutic strategies.